Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 12,630Xls
2D Structure
Also known as: Da-1229, Evogliptin [inn], 1222102-29-5, Chembl1779710, Evogliptin (inn), Da1229
Molecular Formula
C19H26F3N3O3
Molecular Weight
401.4  g/mol
InChI Key
LCDDAGSJHKEABN-MLGOLLRUSA-N
FDA UNII
09118300L7

Evogliptin has been used in trials studying the treatment and screening of Osteoporosis, Renal Impairment, Type 2 Diabetes Mellitus, Diabetes Mellitis Type 2, and Diabetes Mellitus, Type 2.
1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(3R)-4-[(3R)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-[(2-methylpropan-2-yl)oxymethyl]piperazin-2-one
2.1.2 InChI
InChI=1S/C19H26F3N3O3/c1-19(2,3)28-10-16-18(27)24-4-5-25(16)17(26)8-12(23)6-11-7-14(21)15(22)9-13(11)20/h7,9,12,16H,4-6,8,10,23H2,1-3H3,(H,24,27)/t12-,16-/m1/s1
2.1.3 InChI Key
LCDDAGSJHKEABN-MLGOLLRUSA-N
2.1.4 Canonical SMILES
CC(C)(C)OCC1C(=O)NCCN1C(=O)CC(CC2=CC(=C(C=C2F)F)F)N
2.1.5 Isomeric SMILES
CC(C)(C)OC[C@@H]1C(=O)NCCN1C(=O)C[C@@H](CC2=CC(=C(C=C2F)F)F)N
2.2 Other Identifiers
2.2.1 UNII
09118300L7
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 4-(3-amino-4-(2,4,5-trifluorophenyl)butanoyl)-3-(tert-butoxymethyl)piperazin-2-one

2. Da 1229

3. Da-1229

4. Da1229

2.3.2 Depositor-Supplied Synonyms

1. Da-1229

2. Evogliptin [inn]

3. 1222102-29-5

4. Chembl1779710

5. Evogliptin (inn)

6. Da1229

7. (r)-4-((r)-3-amino-4-(2,4,5-trifluorophenyl)-butanoyl)-3-(t-butoxymethyl)-piperazin-2-one

8. (r)-4-((r)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl)-3-(tert-butoxymethyl)piperazin-2-one

9. 2-piperazinone, 4-((3r)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl)-3-((1,1-dimethylethoxy)methyl)-, (3r)-

10. 09118300l7

11. (r)-4-((r)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl)-3-(tert-butoxymethyl)piperazine-2-one

12. Unii-09118300l7

13. Evogliptin [who-dd]

14. Schembl343846

15. Dtxsid00153545

16. Bdbm50344779

17. Db12625

18. Hy-117985

19. Cs-0068793

20. C92448

21. D11023

22. Q25103700

23. (r)-4-[(r)-3-amino-4-(2,4,5-trifluorophenyl) Butanoyl]-3-(t-butoxymethyl)piperazin-2-one

24. (r)-4-[(r)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-(t-butoxymethy)piperazin-2-one

25. (3r)-4-[(3r)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-(tert-butoxymethyl)piperazin-2-one

26. (3r)-4-[(3r)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-[(2-methylpropan-2-yl)oxymethyl]piperazin-2-one

27. (r)-4-[(r)-3-amino-4-(2,4,5-trifluorophenyl) Butanoyl]-3-(t-butoxymethyl)piperazine-2-one

28. 8vu

2.4 Create Date
2008-11-10
3 Chemical and Physical Properties
Molecular Weight 401.4 g/mol
Molecular Formula C19H26F3N3O3
XLogP31
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count7
Rotatable Bond Count7
Exact Mass401.19262619 g/mol
Monoisotopic Mass401.19262619 g/mol
Topological Polar Surface Area84.7 Ų
Heavy Atom Count28
Formal Charge0
Complexity558
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 ATC Code

A - Alimentary tract and metabolism

A10 - Drugs used in diabetes

A10B - Blood glucose lowering drugs, excl. insulins

A10BH - Dipeptidyl peptidase 4 (dpp-4) inhibitors

A10BH07 - Evogliptin